Sort
35,931 grants matching “parkinsons”
Elucidation of regulation and function of amyloid-like assemblies
$398,687Luke E Berchowitz · Columbia University Health Sciences · R35 · FY2020 · GM
Striatal Mechanisms of Dyskinesia and Impulse Control in Parkinsonâs Disease
$398,618Alexandra Nelson · University Of California, San Francisco · R01 · FY2023 · NS
Spatial control of membrane traffic by septin GTPases
$398,598Elias T Spiliotis · University Of Virginia · R35 · FY2024 · GM
Analysis of Synaptic Protein Dynamics
$398,590Jeremy Samuel Dittman · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · NS
Regulation of mitochondrial motility and mitophagy by LRRK2.
$398,538Xinnan Wang · Stanford University · R01 · FY2014 · NS
Dopamine Release Regulation by Co-Released Glutamate and GABA
$398,537Margaret E Rice · New York University School Of Medicine · R01 · FY2016 · DA
The role of lymphatic clearance in brain TB
$398,450Matyas Sandor · University Of Wisconsin-Madison · R01 · FY2024 · NS
Mitochondrial Fidelity and Homeostasis
$398,414Oleh Khalimonchuk · University Of Nebraska Lincoln · R35 · FY2025 · GM
Neural and computational mechanisms of motivation and cognitive control
$398,333Amitai Shenhav · Brown University · R01 · FY2022 · MH
Understanding cell-type vulnerability and oxidative stress pathology in Parkinson's Disease using isogenic human dopaminergic neurons
$398,325Tim Ahfeldt · Icahn School Of Medicine At Mount Sinai · R01 · FY2020 · NS
Understanding Cell-type Vulnerability and Oxidative Stress Pathology in Parkinson's Disease Using Isogenic Human Dopaminergic Neurons
$398,325Joel William Blanchard · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · NS
Understanding cell-type vulnerability and oxidative stress pathology in Parkinson's Disease using isogenic human dopaminergic neurons
$398,325Joel William Blanchard · Icahn School Of Medicine At Mount Sinai · R01 · FY2021 · NS
Understanding cell-type vulnerability and oxidative stress pathology in Parkinson's Disease using isogenic human dopaminergic neurons
$398,325Joel William Blanchard · Icahn School Of Medicine At Mount Sinai · R01 · FY2022 · NS
PACAP/VIP Glycopeptide Agonists as Neuroprotective Therapies for Parkinson's Disease
$398,313Robin Polt · University Of Arizona · R01 · FY2015 · NS
IDENTIFYING MECHANISMS AND TREATMENTS FOR COGNITIVE DECLINE FOLLOWING NEUROTOXIC ALPHA-SYNUCLEIN EXPOSURE IN NEW PARKINSONS DISEASE MODELS
$398,307Augusta University Research Institute, Inc · · FY2022 · Defense Health Agency
Gender Effects on PCB-Induced Dopamine Neurotoxicity
$398,286Richard Field Seegal · Wadsworth Center · R01 · FY2010 · ES
Disability in Parkinson's Disease
$398,268Johns Hopkins University · R01 · FY2001 · HD
Motion and Distortion Robust Diffusion Weighted Imaging Sequences for Pediatric Patients
$398,250Onur Afacan · Boston Children'S Hospital · R01 · FY2025 · NS
A CELL TYPE-SPECIFIC EPIGENETIC AND TRANSCRIPTIONAL PROFILE OF THE DEVELOPMENT OF L-DOPA-INDUCED DYSKINESIA IN A NEUROTOXIN MODEL OF PARKINSON DISEASE
$398,187University Of Alabama At Birmingham · · FY2022 · Defense Health Agency
NEUROSCIENCE EDUCATION--TEACHING BRAIN ATLAS
$398,182Arizona Institute For Bio-Medical Res · R44 · FY2001 · MH
The Role of KCa3.1 in Microglial function and in Parkinsons disease pathogenesis
$398,173Arthi Kanthasamy · University Of Georgia · R01 · FY2021 · NS
Analysis of Septin Structure and Function
$398,165Erfei Bi · University Of Pennsylvania · R01 · FY2024 · GM
Analysis of Septin Structure and Function
$398,165Erfei Bi · University Of Pennsylvania · R01 · FY2023 · GM
Analysis of Septin Structure and Function
$398,165Erfei Bi · University Of Pennsylvania · R01 · FY2022 · GM
The Role of Iduna in Neuroprotection
$398,110Valina L. Dawson · Johns Hopkins University · R01 · FY2009 · NS